US Stock MarketDetailed Quotes

TMO Thermo Fisher Scientific

Watchlist
  • 526.070
  • -1.110-0.21%
Close Dec 27 16:00 ET
  • 526.070
  • 0.0000.00%
Post 20:01 ET
201.22BMarket Cap32.98P/E (TTM)

Thermo Fisher Scientific Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 29, 2024
(Q1)Mar 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jul 1, 2023
(Q1)Apr 1, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0.23%10.6B
-1.37%10.54B
-3.41%10.35B
-4.58%42.86B
-4.93%10.89B
-0.96%10.57B
-2.58%10.69B
-9.38%10.71B
14.55%44.92B
6.99%11.45B
Operating revenue
0.23%10.6B
-1.37%10.54B
-3.41%10.35B
-4.58%42.86B
-4.93%10.89B
-0.96%10.57B
-2.58%10.69B
-9.38%10.71B
14.55%44.92B
6.99%11.45B
Cost of revenue
0.19%6.27B
-3.76%6.19B
-6.54%6.14B
-0.72%25.76B
-5.13%6.49B
-1.84%6.26B
1.02%6.44B
3.40%6.57B
32.55%25.94B
25.62%6.84B
Gross profit
0.28%4.33B
2.26%4.35B
1.57%4.21B
-9.86%17.1B
-4.62%4.39B
0.33%4.32B
-7.57%4.25B
-24.23%4.14B
-3.40%18.97B
-12.33%4.61B
Operating expense
3.21%2.44B
-1.61%2.45B
1.99%2.51B
-6.52%9.78B
-8.59%2.46B
-7.46%2.37B
-3.26%2.49B
-6.66%2.47B
11.17%10.46B
0.75%2.69B
Selling and administrative expenses
2.39%2.1B
-1.59%2.11B
3.02%2.18B
-6.09%8.45B
-7.26%2.13B
-7.20%2.05B
-2.90%2.15B
-6.94%2.12B
12.31%8.99B
0.92%2.3B
Research and development costs
8.46%346M
-1.74%339M
-4.34%331M
-9.11%1.34B
-16.37%327M
-9.12%319M
-5.48%345M
-4.95%346M
4.62%1.47B
-0.26%391M
Operating profit
-3.29%1.88B
7.72%1.9B
0.96%1.69B
-13.98%7.32B
0.94%1.93B
11.76%1.95B
-13.04%1.76B
-40.67%1.68B
-16.80%8.51B
-25.85%1.92B
Net non-operating interest income expense
30.09%-79M
60.14%-59M
45.45%-84M
-9.25%-496M
31.93%-81M
-7.62%-113M
-32.14%-148M
-30.51%-154M
7.91%-454M
20.67%-119M
Non-operating interest income
12.60%277M
65.73%295M
91.10%279M
223.16%879M
106.00%309M
261.76%246M
394.44%178M
711.11%146M
532.56%272M
1,263.64%150M
Non-operating interest expense
-0.84%356M
8.59%354M
21.00%363M
89.39%1.38B
44.98%390M
107.51%359M
120.27%326M
120.59%300M
35.45%726M
67.08%269M
Other net income (expense)
12.86%-61M
60.66%-72M
87.97%-19M
-140.37%-524M
-465.00%-113M
-89.19%-70M
-4,675.00%-183M
4.24%-158M
75.53%-218M
96.50%-20M
Special income (charges)
46.43%-45M
57.92%-77M
74.11%-29M
-302.63%-459M
-45.45%-80M
-154.55%-84M
-662.50%-183M
-5,500.00%-112M
42.13%-114M
-19.57%-55M
-Less：Restructuring and merger&acquisition
-46.43%45M
-57.92%77M
-74.11%29M
302.63%459M
45.45%80M
154.55%84M
662.50%183M
5,500.00%112M
-42.13%114M
19.57%55M
Other non- operating income (expenses)
-214.29%-16M
--5M
121.74%10M
37.50%-65M
-194.29%-33M
450.00%14M
----
71.78%-46M
85.01%-104M
106.65%35M
Income before tax
-1.30%1.74B
23.43%1.77B
16.58%1.59B
-19.62%6.3B
-2.08%1.74B
10.24%1.77B
-25.40%1.43B
-46.34%1.36B
-11.38%7.84B
-4.56%1.78B
Income tax
86.79%99M
146.15%128M
510.87%281M
-59.60%284M
-23.12%133M
70.97%53M
-73.74%52M
-84.72%46M
-36.61%703M
-14.78%173M
Earnings from equity interest net of tax
17.65%-14M
-425.00%-84M
192.00%23M
65.70%-59M
96.67%-1M
76.39%-17M
68.63%-16M
-31.58%-25M
-4,200.00%-172M
---30M
Net income
-3.89%1.63B
14.02%1.55B
3.02%1.33B
-14.44%5.96B
2.03%1.61B
13.15%1.7B
-18.35%1.36B
-41.80%1.29B
-9.94%6.96B
-5.12%1.57B
Net income continuous Operations
-3.89%1.63B
14.02%1.55B
3.02%1.33B
-14.44%5.96B
2.03%1.61B
13.15%1.7B
-18.35%1.36B
-41.80%1.29B
-9.94%6.96B
-5.12%1.57B
Minority interest income
0
500.00%6M
33.33%4M
-500.00%-40M
-1,100.00%-24M
-766.67%-20M
-75.00%1M
-40.00%3M
233.33%10M
-300.00%-2M
Net income attributable to the parent company
-4.96%1.63B
13.74%1.55B
3.03%1.33B
-13.74%6B
3.43%1.63B
14.72%1.72B
-18.21%1.36B
-41.81%1.29B
-10.03%6.95B
-4.95%1.58B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-4.96%1.63B
13.74%1.55B
3.03%1.33B
-13.74%6B
3.43%1.63B
14.72%1.72B
-18.21%1.36B
-41.81%1.29B
-10.03%6.95B
-4.95%1.58B
Basic earnings per share
-4.05%4.26
14.73%4.05
3.89%3.47
-12.56%15.52
4.71%4.22
16.23%4.44
-16.94%3.53
-40.99%3.34
-9.53%17.75
-4.05%4.03
Diluted earnings per share
-3.85%4.25
15.10%4.04
4.22%3.46
-12.37%15.45
4.74%4.2
16.62%4.42
-16.82%3.51
-40.82%3.32
-9.40%17.63
-3.84%4.01
Dividend per share
11.43%0.39
11.43%0.39
11.43%0.39
16.67%1.4
16.67%0.35
16.67%0.35
16.67%0.35
16.67%0.35
15.38%1.2
15.38%0.3
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 29, 2024(Q1)Mar 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jul 1, 2023(Q1)Apr 1, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0.23%10.6B-1.37%10.54B-3.41%10.35B-4.58%42.86B-4.93%10.89B-0.96%10.57B-2.58%10.69B-9.38%10.71B14.55%44.92B6.99%11.45B
Operating revenue 0.23%10.6B-1.37%10.54B-3.41%10.35B-4.58%42.86B-4.93%10.89B-0.96%10.57B-2.58%10.69B-9.38%10.71B14.55%44.92B6.99%11.45B
Cost of revenue 0.19%6.27B-3.76%6.19B-6.54%6.14B-0.72%25.76B-5.13%6.49B-1.84%6.26B1.02%6.44B3.40%6.57B32.55%25.94B25.62%6.84B
Gross profit 0.28%4.33B2.26%4.35B1.57%4.21B-9.86%17.1B-4.62%4.39B0.33%4.32B-7.57%4.25B-24.23%4.14B-3.40%18.97B-12.33%4.61B
Operating expense 3.21%2.44B-1.61%2.45B1.99%2.51B-6.52%9.78B-8.59%2.46B-7.46%2.37B-3.26%2.49B-6.66%2.47B11.17%10.46B0.75%2.69B
Selling and administrative expenses 2.39%2.1B-1.59%2.11B3.02%2.18B-6.09%8.45B-7.26%2.13B-7.20%2.05B-2.90%2.15B-6.94%2.12B12.31%8.99B0.92%2.3B
Research and development costs 8.46%346M-1.74%339M-4.34%331M-9.11%1.34B-16.37%327M-9.12%319M-5.48%345M-4.95%346M4.62%1.47B-0.26%391M
Operating profit -3.29%1.88B7.72%1.9B0.96%1.69B-13.98%7.32B0.94%1.93B11.76%1.95B-13.04%1.76B-40.67%1.68B-16.80%8.51B-25.85%1.92B
Net non-operating interest income expense 30.09%-79M60.14%-59M45.45%-84M-9.25%-496M31.93%-81M-7.62%-113M-32.14%-148M-30.51%-154M7.91%-454M20.67%-119M
Non-operating interest income 12.60%277M65.73%295M91.10%279M223.16%879M106.00%309M261.76%246M394.44%178M711.11%146M532.56%272M1,263.64%150M
Non-operating interest expense -0.84%356M8.59%354M21.00%363M89.39%1.38B44.98%390M107.51%359M120.27%326M120.59%300M35.45%726M67.08%269M
Other net income (expense) 12.86%-61M60.66%-72M87.97%-19M-140.37%-524M-465.00%-113M-89.19%-70M-4,675.00%-183M4.24%-158M75.53%-218M96.50%-20M
Special income (charges) 46.43%-45M57.92%-77M74.11%-29M-302.63%-459M-45.45%-80M-154.55%-84M-662.50%-183M-5,500.00%-112M42.13%-114M-19.57%-55M
-Less：Restructuring and merger&acquisition -46.43%45M-57.92%77M-74.11%29M302.63%459M45.45%80M154.55%84M662.50%183M5,500.00%112M-42.13%114M19.57%55M
Other non- operating income (expenses) -214.29%-16M--5M121.74%10M37.50%-65M-194.29%-33M450.00%14M----71.78%-46M85.01%-104M106.65%35M
Income before tax -1.30%1.74B23.43%1.77B16.58%1.59B-19.62%6.3B-2.08%1.74B10.24%1.77B-25.40%1.43B-46.34%1.36B-11.38%7.84B-4.56%1.78B
Income tax 86.79%99M146.15%128M510.87%281M-59.60%284M-23.12%133M70.97%53M-73.74%52M-84.72%46M-36.61%703M-14.78%173M
Earnings from equity interest net of tax 17.65%-14M-425.00%-84M192.00%23M65.70%-59M96.67%-1M76.39%-17M68.63%-16M-31.58%-25M-4,200.00%-172M---30M
Net income -3.89%1.63B14.02%1.55B3.02%1.33B-14.44%5.96B2.03%1.61B13.15%1.7B-18.35%1.36B-41.80%1.29B-9.94%6.96B-5.12%1.57B
Net income continuous Operations -3.89%1.63B14.02%1.55B3.02%1.33B-14.44%5.96B2.03%1.61B13.15%1.7B-18.35%1.36B-41.80%1.29B-9.94%6.96B-5.12%1.57B
Minority interest income 0500.00%6M33.33%4M-500.00%-40M-1,100.00%-24M-766.67%-20M-75.00%1M-40.00%3M233.33%10M-300.00%-2M
Net income attributable to the parent company -4.96%1.63B13.74%1.55B3.03%1.33B-13.74%6B3.43%1.63B14.72%1.72B-18.21%1.36B-41.81%1.29B-10.03%6.95B-4.95%1.58B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -4.96%1.63B13.74%1.55B3.03%1.33B-13.74%6B3.43%1.63B14.72%1.72B-18.21%1.36B-41.81%1.29B-10.03%6.95B-4.95%1.58B
Basic earnings per share -4.05%4.2614.73%4.053.89%3.47-12.56%15.524.71%4.2216.23%4.44-16.94%3.53-40.99%3.34-9.53%17.75-4.05%4.03
Diluted earnings per share -3.85%4.2515.10%4.044.22%3.46-12.37%15.454.74%4.216.62%4.42-16.82%3.51-40.82%3.32-9.40%17.63-3.84%4.01
Dividend per share 11.43%0.3911.43%0.3911.43%0.3916.67%1.416.67%0.3516.67%0.3516.67%0.3516.67%0.3515.38%1.215.38%0.3
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday-0.10%
Robotics
Robotics
Intraday-1.73%